|
HS Code |
227446 |
As an accredited 2-Methyl-3,5-Dibromopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Methyl-3,5-Dibromopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
2-Methyl-3,5-Dibromopyridine isn’t a household name. For chemists and material scientists, though, this compound opens doors that other reagents simply don’t. Derived from the pyridine ring, decorated with two bromine atoms on the 3 and 5 positions and a methyl group at the 2 position, it’s a chemical with personality. The molecular formula C6H5Br2N already hints at its structure: a six-membered ring, sporting nitrogen, decked with two hefty bromine groups and a subtle but powerful methyl group tucked onto the ring.
Over my years in the lab, I have watched this compound play a modest yet vital role in more synthetic routes than I can count. The combination of electron-rich and electron-deficient ring positions turns it into a unique lever for building larger molecules—something not every halogenated pyridine can claim. It’s no surprise that many who work at the intersection of drug discovery and material innovation look for precisely this kind of chemical backbone.
Every bottle I’ve handled comes as a crystalline solid with a pale, sometimes off-white color. Underneath that unassuming appearance, 2-Methyl-3,5-Dibromopyridine packs a molecular weight of about 250.92 g/mol. The substance lifts out of its bottle with a faintly bitter aroma, the typical scent of halogenated aromatics. It boasts a melting point well above room temperature—a helpful trait for clean handling and shipping. In ethanol or acetonitrile, it dissolves easily, leaving solutions that blend right into reaction protocols without fuss.
Shelf stability rarely turns heads, but with this compound, I’ve left containers for months and returned to crisp, unchanged crystals. Moisture in the air won’t readily break it down. If you have struggled with pyridines decomposing on the shelf, as I once did, there’s real peace of mind with something this robust. Special packing and refrigeration routines become less urgent.
The most important thing about 2-Methyl-3,5-Dibromopyridine? It’s a proven intermediary in building complex molecules. The bromo groups are no accident—they can be swapped out in classic cross-coupling reactions, such as Suzuki or Buchwald-Hartwig aminations, both of which brought my organic classes to life all those semesters ago. Academics love it for method scouting, while industrial plants reach for it in bulk processes.
What does this actually mean in practice? That’s an essential question. The methyl group at the two-position does more than add mass. It changes the way the molecule sits in space, nudging reaction selectivity just enough to build connections that other pyridines can’t provide. In pharmaceutical labs, I’ve watched colleagues use this property to introduce rings and sidechains, usually as part of early-stage candidate development—the tough, unglamorous work that often leads to breakthrough treatments.
Within the walls of a medical chemistry lab, the buzz of routine reactions is constant. In those settings, 2-Methyl-3,5-Dibromopyridine fills a gap in the route toward active pharmaceutical ingredients. Its dual-bromo configuration allows chemists to execute stepwise functionalizations. One bromine can be traded for an aryl or heteroaryl group, the other for an amine, keeping the rest of the ring untouched. The methyl group influences reactivity, sometimes, making certain transformations possible that would stall or run wild on a plain dibromopyridine.
Process chemists after efficiency recognize the value instantly. I still remember those long runs, scaling up five-liter reactors, watching an intermediate develop by NMR—the dibromopyridine’s unmistakable signals always putting me at ease. Watching yields improve thanks to the regioselective flexibility of this molecule changed my thinking about what “versatile” really means in synthesis.
Material science teams, on the flip side, don’t stand idle either. They deploy this molecule into the world of organic electronics. Pyridine-based blocks, especially halogenated ones, serve as the launchpad for conjugated systems in OLEDs and organic photovoltaics. The challenge always comes down to making robust, tunable polymers; the substituent pattern here helps drive packing, charge mobility, and device longevity.
Lots of people ask what separates 2-Methyl-3,5-Dibromopyridine from the usual suspects like plain 3,5-dibromopyridine or the all-too-common 2,6-dibromo variant. For anyone building molecular libraries, these nuanced differences matter. With only two bromines, it’s tempting to think that any dibromopyridine will do. In the real world, substituent-driven differences in reactivity change everything.
The methyl group at the two-position doesn’t just enhance solubility; it shifts the electronic properties of the whole molecule. This subtlety lets the molecule engage in selective reactions. In cross-coupling, I have often noticed that this methyl group can direct incoming groups with more precision, lowering the risk of scrambling and side reactions than with its non-methyl cousin.
Another point: this substance is easier to purify than similar pyridine derivatives. The extra methyl group sets it apart on a silica column—anyone who has spent late nights at a prep bench knows how valuable this can be. Fewer impurities, less wasted time, and less second-guessing if the sample is “clean enough” to move forward.
Modern chemistry rewards flexibility and creativity. These days, speed matters. Academic labs, research startups, and industry giants all chase unique molecules for medicines, electronics, and sensors. Each group faces tight timelines, shrinking budgets, and tough regulatory scrutiny. In drug discovery, every day counts—and that pressure runs upstream to the building blocks.
I saw this clearly during a startup stint focused on kinase inhibitors. The lead series had pyridine cores, and the synthesis route depended on halogen exchange. Many of the team were new postdocs, quick on their feet but frustrated by unreliable chemical stocks. The day we switched our protocol over to 2-Methyl-3,5-Dibromopyridine, side reactions dropped, isolations got easier, and downstream chemistry opened up. For a fledgling group, those wins feel enormous: real progress that translates to new chemical space and new chances at activity.
Material chemists chase much the same thing. They need blocks that deliver cleanly and reliably, sparing them from batch-to-batch guessing games. There’s also the safety angle. With more stable starting materials, the risks associated with hazardous intermediates go down. Regulatory trends increasingly reward predictability and traceability, both of which are easier with compounds that hold up during long runs and scale-outs.
Chemical research never takes place in a vacuum. Confidence in supply chains and technical specs isn’t just an extra—it’s a core demand. I’ve pored through dozens of certificates of analysis looking for consistency, and with reliable 2-Methyl-3,5-Dibromopyridine, lot-to-lot variation falls away. HPLC purity above 98%? That’s become the expected norm. NMR scans match published spectra, and GC-MS readings confirm the compound’s identity each time.
That consistency builds real trust. In regulated industries—especially pharmaceuticals—traceability forms the backbone of good manufacturing practice. By working with well-characterized, high-purity 2-Methyl-3,5-Dibromopyridine, both small and large organizations sidestep the headaches that come from contaminated or mislabeled starting material. QC staff can focus on process issues, not on troubleshooting erratic input.
Drawing from my own time in industrial scale-up, there’s satisfaction and relief every time a run proceeds as planned. Such smoothness often starts with a tested and trusted block, like this pyridine derivative. I have participated in investigations where failures stemmed from unseen impurities or variable isomer ratios—frustrating, expensive, and mostly preventable with proper sourcing.
Sustainability dominates today’s discussions, and chemistry faces its share of public scrutiny. 2-Methyl-3,5-Dibromopyridine, like many halogenated compounds, doesn’t escape these concerns. Disposal and waste management both belong in the conversation. My time in both academic and industrial settings taught me that safe storage and responsible handling go hand-in-hand with good science.
The compound’s stability means researchers generate less hazardous waste compared with less robust options. Degradation doesn’t start spontaneously, so old samples rarely cause surprises during cleanup. For routine handling, standard lab PPE and ventilated hoods work well. Most labs already have disposal streams set for brominated materials. As green chemistry develops, routes that recycle or reclaim bromines may well become standard. For now, thoughtful usage and adherence to local disposal protocols go a long way.
Not every reagent smooths the entire workflow. With 2-Methyl-3,5-Dibromopyridine, the biggest hurdles come from coupling efficiency, especially at scale. Brominated pyridines occasionally need high catalyst loadings or extended reaction times, especially if downstream partners impair the reactivity. Some colleagues opt for microwave reactors to unlock faster kinetics, though this requires equipment outlay.
Solubility, as mentioned, trends positive for this compound but varies by solvent and process setup. Crystallization sometimes complicates workup, requiring a few trial-and-error cycles before getting reliable results at larger scale. From what I’ve seen, a gradual solvent screen and careful monitoring pay for themselves by reducing lost yield and side-product formation.
Supply chain snags pop up from time to time—something that took center stage during pandemic years. Sourcing from reputable vendors with robust validation standards lessens that stress. In my experience, early engagement with suppliers on batch certifications, impurity profiles, and shipping timelines avoids panicked rerouting of critical paths. Collaborative relationships with suppliers work better than repeated one-off orders.
A robust solution to frequent challenges begins with knowledge sharing at all levels. Documentation of successful methods, like those posted in chemistry forums or journal back pages, helps others avoid pitfalls with 2-Methyl-3,5-Dibromopyridine synthesis and use. Open-access procedure repositories cut down on repeat mistakes and speed up adoption of improved methods.
Further upstream, investment in catalyst discovery and greener, more scalable cross-coupling methods offers the real promise of transformation. Research into nickel- or copper-catalyzed reactions continues to lower costs and reduce heavy metal waste in halogen exchange, for example.
On the sourcing front, forging strategic relationships with trusted chemical suppliers helps address batch variability and supply disruptions. I have seen some procurement teams invite vendors for technical briefings, during which detailed Q&A identifies sources of batch inconsistency long before a problem line appears on the shipment manifest. Transparent and frequent communication minimizes supply chain risk.
In education, I’ve noticed that hands-on workshops make a difference when working with new reagents. Providing guided experience—often through university-industry partnerships—demystifies tricky chemistry, shrinking the learning curve for both students and technicians. Such workshops also help embed safe practices and environmental awareness early on.
Having watched chemistry evolve over decades, I see 2-Methyl-3,5-Dibromopyridine not as a miracle cure but as a steady, reliable ally. It offers creative leverage for scientists dreaming up new candidates in pharmaceuticals and high-performance materials. The stability and selectivity it brings to the bench streamlines research and manufacturing, allowing professionals to focus on discovery rather than rescue missions.
Where new compounds often introduce new worries, this one brings a measure of predictability and flexibility—a rare blend. From industry giants mapping out global clinical trials, to small startups running on shoestring budgets, the need for building blocks that deliver on their promises is universal. And in the layered, challenging world of chemistry, that reliability is worth more than gold.
As chemical discovery moves further into the twenty-first century, key intermediates like 2-Methyl-3,5-Dibromopyridine will keep shaping the contours of what’s possible. The room it creates for innovation grows with every successful experiment and each new idea built from its unassuming ring. If my own years at the lab bench have taught me anything, it’s that progress rarely comes from headline-grabbing discoveries alone, but also from the quiet confidence that the basics—done right—make all the difference.